Skip to content
Popular Searches
  • # Cancer
  • # Alzheimer's
  • # FDA
  • # DNA
  • # COVID19
  • # CRISPR
  • linkedin
  • facebook
  • instagram
  • twitter
Home BiotechReality – Covering Industry, Business, and Academia

Explore the frontiers of Biotechnology, Pharma/Biopharma industry and Science with BiotechReality. We publish news, reports, views and articles.

  • Healthcare & Pharmaceuticals
    • Business
    • Pharmacology
  • Clinical Trials
    • Regulatory Approval
  • Biotechnology
    • Molecular Biology
    • Genomics
    • Immunology
    • Microbiology
      • Virology
    • Diagnostic Tests
  • Science
    • Microbiology
    • Research
    • General Biology
  • Technology
    • Artificial Intelligence
  • News
    • Research
Trending

Trending

Diagnosis of prostate cancer made advanced by microscopy plus deep learning

12 March 2024

Biofuel and Types – The Energy of Future; explained

5 January 2024

Molecular map of the human immune response created using next-gen CRISPR tool

14 December 2023

Johnson & Johnson Launches MENTORâ„¢ MemoryGelâ„¢ Breast Implants for Reconstruction Patients

14 May 2025

Zepbound Demonstrates Superior Weight Loss Over Wegovy in Head-to-Head Study – SURMOUNT-5 Phase 3b Clinical Trial Results

12 May 2025

Pfizer’s RSV Lower Respiratory Tract Disease Vaccine ABRYSVO®Approved by European Commission

1 April 2025

An improved prime editing system can do gene-sized edits in human cells at therapeutic levels

13 June 2024

The proteins that enable cellular transportation of particles

17 January 2025

Positive Outcomes From the Initial Prenatal Therapy for Spinal Muscular Atrophy

20 February 2025

Roche’s Supplemental Biologics License Application of Gazyva/Gazyvaro (Obinutuzumab) for The Treatment of Lupus Nephritis Accepted by U.S. FDA

6 March 2025

Scientists Use Artificial Neurons to “Imitate Real Biological Processes”

30 January 2025

Research discovered gene expression regulation in cancer and cellular functions

27 January 2025

Anti-obesity drugs

AbbVie Enters Into the Obesity Drug Market With a License Agreement
Anti-obesity Drugs Business News

AbbVie Enters Into the Obesity Drug Market With a License Agreement

Editor's Desk 5 March 2025

GUB014295 is a calcitonin and amylin receptor-specific agonist that may be a long-acting amylin analog.

Areas Covered

  • Anti-obesity Drugs
  • Applications of Biotechnology
  • Artificial Intelligence
  • Astrobiology
  • Biochemistry
  • Bioengineering
  • Bioinformatics
  • Biostatistics
  • Biotechnology
  • Blog
  • Business
  • Cancer
  • Cell Biology
  • Clinical Investigation
  • Clinical Trials
  • Collection
  • Deep Learning
  • Diabetes
  • Diagnostic Tests
  • Disease Biology
  • Diseases
  • Drug Discovery
  • Drugs
  • Engineering
  • Epidemiology
  • Gene Therapy
  • General Biology
  • Genetics
  • Genomics
  • Healthcare & Pharmaceuticals
  • Immunology
  • Immunotherapy
  • Instrumentation
  • Laboratory Info
  • Life Sciences
  • Machine Learning
  • Medical Devices
  • Mental Health
  • Microbiology
  • Microscopy
  • Molecular Biology
  • Nanotechnology
  • Neuroscience
  • News
  • Pharmacology
  • Regenerative Medicine
  • Regulatory
  • Regulatory Approval
  • Research
  • Science
  • Science Communication
  • Staining
  • Technology
  • Therapies
  • Toxicology
  • Vaccines
  • Virology
  • Weight-loss Drugs
Market Analysis
Publish on BiotechReality

  • Amgen Hiring Senior Data Engineer in Hyderabad, India – May 2025
  • Novo Nordisk Hiring Senior Regulatory Affairs Specialist in Seoul, South Korea – May 2025
  • Pfizer Hiring an IT Senior Associate in Chennai, India – April, 2025
  • IQVIA Hiring Clinical Data Specialist in Cochin, India – April 2025
  • Amgen Hiring CRM Engineer (Veeva/Salesforce) in Hyderabad, India – April, 2025
SciRealityPress BiotechReality

A SciRealityPress Associate

Contents in the website is licensed under CC BY-NC 4.0

Disclaimer: The content on this website is not meant to provide medical or any other professional advice. Understand and use the information, double check if necessary. All trademarked names mentioned in the contents belongs to their respective owners. Stock exchange data providing by Stockdio

SciRealityPress © 2025
  • About
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
  • Platform Status
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinuePrivacy policy